Context Low-risk differentiated thyroid cancer (DTC) is overdiagnosed, but true incidence
has increased as well. Owing to its excellent prognosis with low morbidity and mortality …

Background: Radioiodine remnant ablation (RRA) has traditionally been one of the
cornerstones of differentiated thyroid cancer (DTC) treatment. The decision to use RRA in …

Background: In response to evidence of overdiagnosis and overtreatment of papillary thyroid
carcinoma (PTC), the 2009 and 2015 American Thyroid Association (ATA) adult guidelines …

Background: Little is known about cancer-related worry in thyroid cancer survivors with
favorable prognosis. Methods: A diverse cohort of patients diagnosed with differentiated …

Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Context: Little is known about cancer-related worry in thyroid cancer survivors. Objectives:
We quantified cancer-related worry in Canadian thyroid cancer survivors and explored …

Background: Radioactive iodine (RAI) ablation is frequently performed after initial surgery for
well-differentiated thyroid cancer (WDTC). We examined the frequency and timing of …

PURPOSE To understand the effect of patient preferences on thyroid cancer surveillance
intensity. PATIENTS AND METHODS Eligible patients diagnosed with thyroid cancer …

PURPOSE For many patients with differentiated thyroid cancer, use of radioactive iodine
(RAI) does not improve survival or reduce recurrence risk. Yet there is wide variation in RAI …

Purpose The purpose of this study is to understand physician management of thyroid cancer-
related worry. Methods Endocrinologists, general surgeons, and otolaryngologists identified …